Immunology
Fundamental advance in understanding T cell immunity
Monash University researchers have provided a fundamental advance regarding how T cells become activated when encountering pathogens such as viruses.
Jun 4, 2021
0
25
Page 6 - News tagged with t cell receptor
Medical research
UCSD patient gets first cancer treatment made from stem cells
A new form of cancer immunotherapy has been given to a University of California, San Diego Health patient in the first test of immune cells grown from stem cells.
Apr 16, 2019
0
103
Oncology & Cancer
Research team discovers new target for CAR T cells in solid tumors
Chimeric antigen receptor T-cell therapy, or CAR T, has made a big impact on the treatment of certain blood cancers, allowing patients with relapsed/refractory disease to live longer, healthier lives. But in clinical study, ...
May 5, 2022
0
51
HIV & AIDS
Gene therapy reduces HIV levels in small trials
(Medical Xpress) -- This weekend at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Chicago, Illinois, researchers from two different study groups, one on the east coast and one on the west coast, ...
Oncology & Cancer
Majority of patients responded in CAR T-cell trial for mantle cell lymphoma
A one-year follow-up study led by The University of Texas MD Anderson Cancer Center revealed a majority of patients with mantle cell lymphoma resistant to prior therapies may benefit from treatment with CD19-targeting chimeric ...
Apr 1, 2020
0
13
Immunology
Virus-mimicking drug helps immune system target cunning cancer cells
Researchers at the UCLA Jonsson Comprehensive Cancer Center have found that a drug that activates the body's natural defenses by behaving like a virus may also make certain stealthy melanoma tumors visible to the immune system, ...
Oct 14, 2020
0
84
Oncology & Cancer
Researchers expanding the types of cancer CAR-T therapy can target
Teaching the body's immune cells to recognize and fight cancer is one of the holy grails in medicine. Over the past two decades, researchers have developed new immunotherapy drugs that stimulate a patient's immune cells to ...
Dec 16, 2022
0
3
Immunology
'Black sheep' of helper T cells may hold key to precision allergy treatment
A new Nature Immunology study led by University of Pittsburgh and National Institutes of Health researchers sheds light on how a rare type of helper T cell, called Th9, can drive allergic disease, suggesting new precision ...
May 3, 2023
0
42
Oncology & Cancer
Engineered bacteria paint targets on tumors for cancer-killing T cells to see
For several years, researchers have been successfully using chimeric antigen receptor (CAR) T cells to target specific antigens found on blood cells as a cure for patients with leukemia and lymphoma. But solid tumors, like ...
Oct 12, 2023
0
33
Oncology & Cancer
Programming the immune system to supercharge cancer cell therapies
The first FDA-approved gene therapies are living drugs: immune cells taken from cancer patients engineered to target tumor cells. However, for many patients, these advanced therapies do not result in a long-lasting remission. ...
Mar 16, 2022
0
95
